RA Capital Management, LLC, Director, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 850,000 shares at $8.50 ($7.2M) on 2017-10-12, disclosed to the SEC on 2017-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |